US5162512A
(en)
*
|
1982-03-09 |
1992-11-10 |
Cytogen Corporation |
Amine derivatives of anthracycline antibodies
|
US5140104A
(en)
*
|
1982-03-09 |
1992-08-18 |
Cytogen Corporation |
Amine derivatives of folic acid analogs
|
CA1203164A
(en)
*
|
1982-03-09 |
1986-04-15 |
Thomas J. Mckearn |
Antibody conjugates
|
JPS59116229A
(ja)
*
|
1982-12-24 |
1984-07-05 |
Teijin Ltd |
細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
|
JPS59116232A
(ja)
*
|
1982-12-24 |
1984-07-05 |
Teijin Ltd |
細胞毒性複合体及びその製造法
|
EP0140896A1
(en)
*
|
1983-04-18 |
1985-05-15 |
Quidel |
Protection of antibody during chemical modification
|
EP0141818A1
(en)
*
|
1983-04-18 |
1985-05-22 |
Quidel |
Removal of self-binding and staph a cross-reactivity of anti-strep antibody
|
AU582341B2
(en)
*
|
1984-01-27 |
1989-03-23 |
Molecular Biosystems, Inc. |
Assay for immobilized reporter groups
|
US4837003A
(en)
*
|
1984-09-13 |
1989-06-06 |
Mallinckrodt, Inc. |
Radiolabeled antibody fragments
|
JPS62500175A
(ja)
*
|
1984-09-13 |
1987-01-22 |
サイトジエン コ−ポレ−シヨン |
抗体−治療剤接合体
|
AU583854B2
(en)
*
|
1984-09-13 |
1989-05-11 |
Cytogen Corporation |
Antibody therapeutic agent conjugates
|
FR2573627B1
(fr)
*
|
1984-11-29 |
1986-12-26 |
Entremont Sa |
Procede pour la fabrication de produits laitiers au moyen d'anticorps
|
FR2577135B1
(fr)
*
|
1985-02-13 |
1989-12-15 |
Sanofi Sa |
Immunotoxines a longue duree d'action comportant un constituant glycopeptidique inactivant les ribosomes modifie sur ses motifs polysaccharidiques
|
IL78775A
(en)
*
|
1985-05-15 |
1992-06-21 |
Biotech Australia Pty Ltd |
Oral vaccines
|
US4824659A
(en)
*
|
1985-06-07 |
1989-04-25 |
Immunomedics, Inc. |
Antibody conjugates
|
NZ212437A
(en)
*
|
1985-06-17 |
1992-06-25 |
Mark Philip Best |
Site-directed antibody conjugates, and their preparation
|
US5405966A
(en)
*
|
1985-10-17 |
1995-04-11 |
Theodore; Louis J. |
Trichothecene conjugates
|
US4744981A
(en)
*
|
1985-10-17 |
1988-05-17 |
Neorx Corporation |
Trichothecene antibody conjugates
|
WO1987003206A1
(en)
*
|
1985-11-25 |
1987-06-04 |
Quash Gerard A |
Modified viral glycoproteins, diagnostic and therapeutic uses therefore
|
FR2590674B1
(fr)
*
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
EP0232693A3
(fr)
*
|
1985-12-16 |
1988-04-06 |
La Region Wallonne |
Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
|
US4911911A
(en)
*
|
1985-12-20 |
1990-03-27 |
Sanofi |
Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein
|
FR2591895B1
(fr)
*
|
1985-12-20 |
1988-08-26 |
Sanofi Sa |
Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques
|
FR2591894B1
(fr)
*
|
1985-12-20 |
1988-04-01 |
Sanofi Sa |
Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques
|
IL80973A
(en)
*
|
1985-12-20 |
1992-08-18 |
Sanofi Sa |
Modified ribosome-inactivating glycoproteins,their preparation,immunotoxins containing them and pharmaceutical compositions containing such immunotoxins
|
US5057313A
(en)
*
|
1986-02-25 |
1991-10-15 |
The Center For Molecular Medicine And Immunology |
Diagnostic and therapeutic antibody conjugates
|
US4699784A
(en)
*
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
US4797491A
(en)
*
|
1986-03-17 |
1989-01-10 |
Cetus Corporation |
Compound 1-(3-(2-pyridyldithio)propionamido)-12-(5-hydrazidoglutaramido)-4,9-dioxadodecane
|
US5276140A
(en)
*
|
1986-03-17 |
1994-01-04 |
Cetus Oncology Corporation |
Cross-linking agents
|
US5190864A
(en)
*
|
1986-04-15 |
1993-03-02 |
Northeastern University |
Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
|
US4937188A
(en)
*
|
1986-04-15 |
1990-06-26 |
Northeastern University |
Enzyme activity amplification method for increasing assay sensitivity
|
US6673347B1
(en)
|
1986-04-30 |
2004-01-06 |
Gryphon Therapeutics |
Polypeptide and protein derivatives and process for their preparation
|
GB8610551D0
(en)
*
|
1986-04-30 |
1986-06-04 |
Hoffmann La Roche |
Polypeptide & protein derivatives
|
US5194254A
(en)
*
|
1986-05-06 |
1993-03-16 |
Connaught Laboratories Limited |
Enhancement of antigen immunogenicity
|
GB8610983D0
(en)
*
|
1986-05-06 |
1986-06-11 |
Connaught Lab |
Enhancement of antigen immunogenicity
|
CA1330378C
(en)
*
|
1986-05-08 |
1994-06-21 |
Daniel J. Coughlin |
Amine derivatives of folic acid analogs
|
US4801688A
(en)
*
|
1986-05-27 |
1989-01-31 |
Eli Lilly And Company |
Hydrazone immunoglobulin conjugates
|
US4814438A
(en)
*
|
1986-12-24 |
1989-03-21 |
Eli Lilly And Company |
Immunoglobulin conjugates of 2',2'-difluronucleosides
|
US4994558A
(en)
*
|
1986-12-24 |
1991-02-19 |
Eli Lilly And Company |
Immunoglobulin conjugates
|
FR2610198B1
(fr)
*
|
1987-02-03 |
1990-06-15 |
Ire Celltarg Sa |
Conjugues d'hydrazide d'alcaloide de vinca lie a une immunoglobuline, procede de preparation et compositions pharmaceutiques en comprenant
|
US4874813A
(en)
*
|
1987-02-09 |
1989-10-17 |
Shannessy Daniel J O |
Proteins bound to a marker or solid phase support matrix using a hydrazone linkage
|
US5227474A
(en)
*
|
1987-02-13 |
1993-07-13 |
Abbott Laboratories |
Bifunctional chelating agents
|
US5057302A
(en)
*
|
1987-02-13 |
1991-10-15 |
Abbott Laboratories |
Bifunctional chelating agents
|
US4793986A
(en)
*
|
1987-02-25 |
1988-12-27 |
Johnson Matthey, Inc. |
Macromolecular platinum antitumor compounds
|
US5225541A
(en)
*
|
1987-03-05 |
1993-07-06 |
Peralta Cancer Research Institute |
Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated to a detectable moiety and a kit containing the antibody
|
WO1988007553A1
(en)
*
|
1987-03-26 |
1988-10-06 |
Teijin Limited |
Process for preparing antibody complex
|
EP0303406A3
(en)
*
|
1987-08-14 |
1991-07-03 |
Hewlett-Packard Company |
An immunoaffinity substrate
|
US4981979A
(en)
*
|
1987-09-10 |
1991-01-01 |
Neorx Corporation |
Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
|
US5336603A
(en)
*
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
US6710169B2
(en)
|
1987-10-02 |
2004-03-23 |
Genentech, Inc. |
Adheson variants
|
DE3738721C2
(de)
*
|
1987-11-14 |
1995-10-05 |
Roehm Gmbh |
Immobilisierte Antikörper
|
JPH02503921A
(ja)
*
|
1988-02-08 |
1990-11-15 |
サイトゲン コーポレーション |
化合物の部位特異結合のための新規で改良された抗体
|
CA1339775C
(en)
*
|
1988-06-10 |
1998-03-24 |
Shuzo Matsushita |
Antibody 0.5b to hiv-i gp 120 modified with toxic substance
|
US5094849A
(en)
*
|
1988-08-08 |
1992-03-10 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
|
US5144012A
(en)
*
|
1988-08-08 |
1992-09-01 |
Eli Lilly And Company |
Cytotoxic drug conjugates
|
US5028697A
(en)
*
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
US5006652A
(en)
*
|
1988-08-08 |
1991-04-09 |
Eli Lilly And Company |
Intermediates for antibody-vinca drug conjugates
|
DE3839020A1
(de)
*
|
1988-11-18 |
1990-05-23 |
Roehm Gmbh |
Fixierung von proteinen an festen traegern
|
AU5349290A
(en)
*
|
1989-03-13 |
1990-10-09 |
Kenneth Naoyuki Matsumura |
Method for reducing side effects of a drug
|
IE901736L
(en)
*
|
1989-05-17 |
1990-11-17 |
Fuller H B Licensing Financ |
Polypeptide-antibody conjugate for inhibiting cell adhesion
|
US5112946A
(en)
*
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
CA1339415C
(en)
*
|
1989-08-24 |
1997-09-02 |
Milton David Goldenberg |
Detection and treatment of infections with immunoconjugates
|
US5273743A
(en)
*
|
1990-03-09 |
1993-12-28 |
Hybritech Incorporated |
Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
|
US5091542A
(en)
*
|
1990-03-09 |
1992-02-25 |
Hybritech Incorporated |
Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
|
WO1991016324A1
(en)
*
|
1990-04-25 |
1991-10-31 |
The Upjohn Company |
Novel cc-1065 analogs
|
US5082929A
(en)
*
|
1990-08-08 |
1992-01-21 |
Bioprobe International, Inc. |
Immobilization of glycocompounds and glycoconjugates
|
WO1992005200A1
(en)
*
|
1990-09-18 |
1992-04-02 |
Chemex Pharmaceuticals, Inc. |
Xenobiotic-antibody conjugates
|
US5272253A
(en)
*
|
1991-07-01 |
1993-12-21 |
Eli Lilly And Company |
Cluster conjugates of drugs with antibodies
|
WO1993002192A1
(en)
*
|
1991-07-15 |
1993-02-04 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
ATE252890T1
(de)
*
|
1992-03-23 |
2003-11-15 |
Kenneth Naoyuki Matsumura |
Zusammensetzung zur verminderung von nebenwirkungen eines arzneimittels
|
GR1001459B
(el)
*
|
1992-10-08 |
1993-12-30 |
Lilly Co Eli |
Σύμπλεγμα συζυγών φαρμάκων με αντισώματα.
|
AU693433B2
(en)
*
|
1992-12-21 |
1998-07-02 |
Promega Corporation |
Prevention and treatment of sepsis
|
US6103236A
(en)
*
|
1995-05-10 |
2000-08-15 |
Kyowa Hakko Kogyo Co., Ltd. |
Toxin conjugates
|
AU5920096A
(en)
*
|
1995-05-15 |
1996-11-29 |
Constantin A. Bona |
Carbohydrate-mediated coupling of peptides to immunoglobulins
|
US5712374A
(en)
*
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
WO1996040662A2
(en)
*
|
1995-06-07 |
1996-12-19 |
Cellpro, Incorporated |
Aminooxy-containing linker compounds and their application in conjugates
|
US5980883A
(en)
*
|
1996-10-02 |
1999-11-09 |
Kuraray Co., Ltd. |
Polymer gel for medical use
|
EP1283720B1
(en)
*
|
2000-05-26 |
2007-04-18 |
Symphogen A/S |
Recombinant or purified polyclonal antibodies for treating allergy
|
JP2002353075A
(ja)
*
|
2001-03-21 |
2002-12-06 |
Morinobu Endo |
電気二重層コンデンサの電極材料およびこれを用いた電気二重層コンデンサ
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
WO2007098755A1
(en)
*
|
2006-03-01 |
2007-09-07 |
Toxispot A/S |
A method for obtaining a microarray and an assay
|
DE102007002726A1
(de)
|
2007-01-18 |
2008-07-31 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
|
EP3360571B1
(en)
|
2007-05-03 |
2020-12-16 |
Agency For Science, Technology And Research (A*star) |
Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
|
US8865875B2
(en)
|
2007-08-22 |
2014-10-21 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions
|
PT2542576T
(pt)
*
|
2010-03-02 |
2016-07-14 |
Seattle Genetics Inc |
Métodos para rastreio de anticorpos
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
CN108129554A
(zh)
|
2010-08-10 |
2018-06-08 |
洛桑聚合联合学院 |
红细胞结合性治疗剂
|
CN103403011A
(zh)
*
|
2011-01-31 |
2013-11-20 |
Eth苏黎世公司 |
三官能交联试剂
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
EP3909603A1
(en)
|
2014-02-21 |
2021-11-17 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Glycotargeting therapeutics
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
EP3638296A1
(en)
|
2017-06-16 |
2020-04-22 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
CN113289587B
(zh)
*
|
2021-05-10 |
2023-11-28 |
苏州君盟生物医药科技有限公司 |
巯基修饰的磁性纳米微球及其制备方法、应用
|